"By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Oxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Oxacillin interferes with an autolysin inhibitor."@en . . . . "Oxazocillin"@en . . . "(2S,5R,6R)-3,3-Dimethyl-6-{[(5-methyl-3-phenylisoxazol-4-yl)carbonyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"@en . "An antibiotic similar to flucloxacillin used in resistant staphylococci infections. [PubChem]"@en . . . . . . . . . . . . . "Oxacilline"@en . . . . . . . . "66-79-5"@en . . . "20 to 30 minutes"@en . . . . . . . . . . . . . "Oxacillin Sodium is rapidly excreted as unchanged drug in the urine by glomerular filtration and active tubular secretion."@en . "(5-Methyl-3-phenyl-4-isoxazolyl)penicillin"@en . . "5-Methyl-3-phenyl-4-isoxazolyl-penicillin"@en . . . . . . . "Oxacillinum"@en . " "@en . . "Oxacilina"@en . . . "Oxazocilline"@en . . "Used in the treatment of resistant staphylococci infections."@en . . "Oxacillin"@en . "6beta-(5-Methyl-3-phenylisoxazol-4-yl)penicillanic acid"@en . . "94.2 +/- 2.1% (binds to serum protein, mainly albumin)"@en . . "approved"@en . . . . "Staphylococcus aureus"@en . . . . . . . . . . "Oxacillin"@en . . . . . . . . . . . " "@en . . . . . "Enteric bacteria and other eubacteria"@en . .